PubMed:10377075
Annnotations
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 1714-1717 | DiseaseOrPhenotypicFeature | denotes | can | 0012833 |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 46-79 | protein | denotes | vascular cell adhesion molecule-1 |
| T2 | 94-117 | cell_type | denotes | human endothelial cells |
| T3 | 317-335 | protein | denotes | adhesion molecules |
| T4 | 339-342 | cell_type | denotes | ECs |
| T5 | 396-444 | protein | denotes | Peroxisome proliferator-activated receptor-alpha |
| T6 | 446-455 | protein | denotes | PPARalpha |
| T7 | 474-497 | protein | denotes | nuclear receptor family |
| T8 | 620-629 | protein | denotes | PPARalpha |
| T9 | 644-653 | cell_type | denotes | human ECs |
| T10 | 678-711 | protein | denotes | vascular cell adhesion molecule-1 |
| T11 | 713-719 | protein | denotes | VCAM-1 |
| T12 | 778-802 | cell_type | denotes | human carotid artery ECs |
| T13 | 811-820 | protein | denotes | PPARalpha |
| T14 | 838-856 | cell_type | denotes | cultured human ECs |
| T15 | 866-875 | protein | denotes | PPARalpha |
| T16 | 920-944 | protein | denotes | TNF-alpha-induced VCAM-1 |
| T17 | 1016-1025 | protein | denotes | PPARgamma |
| T18 | 1043-1052 | protein | denotes | PPARalpha |
| T19 | 1091-1097 | protein | denotes | VCAM-1 |
| T20 | 1188-1214 | DNA | denotes | VCAM-1 promoter constructs |
| T21 | 1291-1297 | protein | denotes | VCAM-1 |
| T22 | 1334-1343 | protein | denotes | NF-kappaB |
| T23 | 1354-1363 | protein | denotes | PPARalpha |
| T24 | 1409-1419 | cell_line | denotes | U937 cells |
| T25 | 1423-1441 | cell_type | denotes | cultured human ECs |
| T26 | 1456-1465 | cell_type | denotes | Human ECs |
| T27 | 1474-1483 | protein | denotes | PPARalpha |
| T28 | 1575-1581 | protein | denotes | VCAM-1 |
| T29 | 1727-1736 | protein | denotes | PPARalpha |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-118 | Sentence | denotes | PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. |
| S2 | 119-262 | Sentence | denotes | BACKGROUND: Adhesion molecule expression on the endothelial cell (EC) surface is critical for leukocyte recruitment to atherosclerotic lesions. |
| S3 | 263-395 | Sentence | denotes | Better understanding of transcriptional regulation of adhesion molecules in ECs may provide important insight into plaque formation. |
| S4 | 396-588 | Sentence | denotes | Peroxisome proliferator-activated receptor-alpha (PPARalpha), a member of the nuclear receptor family, regulates gene expression in response to certain fatty acids and fibric acid derivatives. |
| S5 | 589-721 | Sentence | denotes | The present study investigated PPARalpha expression in human ECs and their regulation of vascular cell adhesion molecule-1 (VCAM-1). |
| S6 | 722-821 | Sentence | denotes | METHODS AND RESULTS: Immunohistochemistry revealed that human carotid artery ECs express PPARalpha. |
| S7 | 822-1037 | Sentence | denotes | Pretreatment of cultured human ECs with the PPARalpha activators fenofibrate or WY14643 inhibited TNF-alpha-induced VCAM-1 in a time- and concentration-dependent manner, an effect not seen with PPARgamma activators. |
| S8 | 1038-1150 | Sentence | denotes | Both PPARalpha activators decreased cytokine-induced VCAM-1 mRNA expression without altering its mRNA half-life. |
| S9 | 1151-1344 | Sentence | denotes | Transient transfection of deletional VCAM-1 promoter constructs and electrophoretic mobility shift assays suggest that fenofibrate inhibits VCAM-1 transcription in part by inhibiting NF-kappaB. |
| S10 | 1345-1442 | Sentence | denotes | Finally, PPARalpha activators significantly reduced adhesion of U937 cells to cultured human ECs. |
| S11 | 1443-1598 | Sentence | denotes | CONCLUSIONS: Human ECs express PPARalpha, a potentially important regulator of atherogenesis through its transcriptional control of VCAM-1 gene expression. |
| S12 | 1599-1737 | Sentence | denotes | Such findings also have implications regarding the clinical use of lipid-lowering agents, like fibric acids, which can activate PPARalpha. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-20 | NP | denotes | PPARalpha activators |
| C2 | 94-117 | NP | denotes | human endothelial cells |
| C3 | 339-342 | NP | denotes | ECs |
| C4 | 396-456 | NP | denotes | Peroxisome proliferator-activated receptor-alpha (PPARalpha) |
| C5 | 458-497 | NP | denotes | a member of the nuclear receptor family |
| C6 | 644-653 | NP | denotes | human ECs |
| C7 | 658-663 | NP | denotes | their |
| C8 | 811-820 | NP | denotes | PPARalpha |
| C9 | 838-856 | NP | denotes | cultured human ECs |
| C10 | 862-909 | NP | denotes | the PPARalpha activators fenofibrate or WY14643 |
| C11 | 1038-1063 | NP | denotes | Both PPARalpha activators |
| C12 | 1354-1374 | NP | denotes | PPARalpha activators |
| C13 | 1423-1441 | NP | denotes | cultured human ECs |
| C14 | 1456-1465 | NP | denotes | Human ECs |
| C15 | 1474-1483 | NP | denotes | PPARalpha |
| C16 | 1485-1535 | NP | denotes | a potentially important regulator of atherogenesis |
| C17 | 1544-1547 | NP | denotes | its |
| C18 | 1666-1706 | NP | denotes | lipid-lowering agents, like fibric acids |
| C19 | 1708-1713 | NP | denotes | which |
| C20 | 1727-1736 | NP | denotes | PPARalpha |
| R1 | C3 | C2 | coref-ident | ECs,human endothelial cells |
| R2 | C5 | C4 | coref-appos | a member of the nuclear receptor family,Peroxisome proliferator-activated receptor-alpha (PPARalpha) |
| R3 | C6 | C3 | coref-ident | human ECs,ECs |
| R4 | C7 | C4 | coref-pron | their,Peroxisome proliferator-activated receptor-alpha (PPARalpha) |
| R5 | C8 | C4 | coref-ident | PPARalpha,Peroxisome proliferator-activated receptor-alpha (PPARalpha) |
| R6 | C10 | C1 | coref-ident | the PPARalpha activators fenofibrate or WY14643,PPARalpha activators |
| R7 | C11 | C10 | coref-ident | Both PPARalpha activators,the PPARalpha activators fenofibrate or WY14643 |
| R8 | C12 | C11 | coref-ident | PPARalpha activators,Both PPARalpha activators |
| R9 | C13 | C9 | coref-ident | cultured human ECs,cultured human ECs |
| R10 | C14 | C6 | coref-ident | Human ECs,human ECs |
| R11 | C15 | C8 | coref-ident | PPARalpha,PPARalpha |
| R12 | C16 | C15 | coref-appos | a potentially important regulator of atherogenesis,PPARalpha |
| R13 | C17 | C15 | coref-pron | its,PPARalpha |
| R14 | C19 | C18 | coref-relat | which,"lipid-lowering agents, like fibric acids" |
| R15 | C20 | C15 | coref-ident | PPARalpha,PPARalpha |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-20 | other_organic_compound | denotes | PPARalpha activators |
| T2 | 29-45 | other_name | denotes | cytokine-induced |
| T3 | 46-79 | protein_molecule | denotes | vascular cell adhesion molecule-1 |
| T4 | 94-117 | cell_type | denotes | human endothelial cells |
| T5 | 131-159 | other_name | denotes | Adhesion molecule expression |
| T6 | 167-196 | cell_component | denotes | endothelial cell (EC) surface |
| T7 | 213-234 | other_name | denotes | leukocyte recruitment |
| T8 | 238-261 | other_name | denotes | atherosclerotic lesions |
| T9 | 287-313 | other_name | denotes | transcriptional regulation |
| T10 | 317-335 | protein_family_or_group | denotes | adhesion molecules |
| T11 | 339-342 | cell_type | denotes | ECs |
| T12 | 378-394 | other_name | denotes | plaque formation |
| T13 | 396-406 | cell_type | denotes | Peroxisome |
| T14 | 446-455 | protein_molecule | denotes | PPARalpha |
| T15 | 474-497 | protein_family_or_group | denotes | nuclear receptor family |
| T16 | 509-524 | other_name | denotes | gene expression |
| T17 | 548-559 | lipid | denotes | fatty acids |
| T18 | 620-629 | protein_molecule | denotes | PPARalpha |
| T19 | 644-649 | cell_type | denotes | human |
| T20 | 650-653 | cell_type | denotes | ECs |
| T21 | 678-711 | protein_molecule | denotes | vascular cell adhesion molecule-1 |
| T22 | 713-719 | protein_molecule | denotes | VCAM-1 |
| T23 | 743-763 | other_name | denotes | Immunohistochemistry |
| T24 | 778-798 | cell_type | denotes | human carotid artery |
| T25 | 799-802 | cell_type | denotes | ECs |
| T26 | 811-820 | protein_molecule | denotes | PPARalpha |
| T27 | 838-852 | cell_type | denotes | cultured human |
| T28 | 853-856 | cell_type | denotes | ECs |
| T29 | 866-875 | protein_molecule | denotes | PPARalpha |
| T30 | 887-898 | other_artificial_source | denotes | fenofibrate |
| T31 | 902-909 | other_artificial_source | denotes | WY14643 |
| T32 | 920-937 | protein_molecule | denotes | TNF-alpha-induced |
| T33 | 938-944 | protein_molecule | denotes | VCAM-1 |
| T34 | 1016-1025 | protein_molecule | denotes | PPARgamma |
| T35 | 1043-1052 | protein_molecule | denotes | PPARalpha |
| T36 | 1091-1097 | protein_molecule | denotes | VCAM-1 |
| T37 | 1135-1149 | other_name | denotes | mRNA half-life |
| T38 | 1188-1194 | protein_molecule | denotes | VCAM-1 |
| T39 | 1219-1256 | other_name | denotes | electrophoretic mobility shift assays |
| T40 | 1270-1281 | other_artificial_source | denotes | fenofibrate |
| T41 | 1291-1297 | protein_molecule | denotes | VCAM-1 |
| T42 | 1334-1343 | protein_complex | denotes | NF-kappaB |
| T43 | 1354-1363 | protein_molecule | denotes | PPARalpha |
| T44 | 1389-1405 | other_name | denotes | reduced adhesion |
| T45 | 1409-1419 | cell_line | denotes | U937 cells |
| T46 | 1423-1441 | cell_type | denotes | cultured human ECs |
| T47 | 1456-1465 | cell_type | denotes | Human ECs |
| T48 | 1474-1483 | protein_molecule | denotes | PPARalpha |
| T49 | 1522-1535 | other_name | denotes | atherogenesis |
| T50 | 1575-1581 | protein_molecule | denotes | VCAM-1 |
| T51 | 1666-1687 | other_name | denotes | lipid-lowering agents |
| T52 | 1694-1706 | other_organic_compound | denotes | fibric acids |
| T53 | 1727-1736 | protein_molecule | denotes | PPARalpha |
2015-BEL-Sample-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| BEL:20066350 | 0-549 | tscript(p(HGNC:PPARA)) decreases r(HGNC:VCAM1) | denotes | PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. BACKGROUND: Adhesion molecule expression on the endothelial cell (EC) surface is critical for leukocyte recruitment to atherosclerotic lesions. Better understanding of transcriptional regulation of adhesion molecules in ECs may provide important insight into plaque formation. Peroxisome proliferator-activated receptor-alpha (PPARalpha), a member of the nuclear receptor family, regulates gene expression in response to certain f |
| BEL:20066350 | 0-549 | tscript(p(HGNC:PPARA)) decreases r(HGNC:VCAM1) | denotes | PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. BACKGROUND: Adhesion molecule expression on the endothelial cell (EC) surface is critical for leukocyte recruitment to atherosclerotic lesions. Better understanding of transcriptional regulation of adhesion molecules in ECs may provide important insight into plaque formation. Peroxisome proliferator-activated receptor-alpha (PPARalpha), a member of the nuclear receptor family, regulates gene expression in response to certain f |
| BEL:20045996 | 0-721 | p(HGNC:VCAM1) increases bp(GOBP:"cell adhesion") | denotes | PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. BACKGROUND: Adhesion molecule expression on the endothelial cell (EC) surface is critical for leukocyte recruitment to atherosclerotic lesions. Better understanding of transcriptional regulation of adhesion molecules in ECs may provide important insight into plaque formation. Peroxisome proliferator-activated receptor-alpha (PPARalpha), a member of the nuclear receptor family, regulates gene expression in response to certain fatty acids and fibric acid derivatives. The present study investigated PPARalpha expression in human ECs and their regulation of vascular cell adhesion molecule-1 (VCAM-1). |
| BEL:20045756 | 0-720 | p(HGNC:TNF) increases r(HGNC:VCAM1) | denotes | PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. BACKGROUND: Adhesion molecule expression on the endothelial cell (EC) surface is critical for leukocyte recruitment to atherosclerotic lesions. Better understanding of transcriptional regulation of adhesion molecules in ECs may provide important insight into plaque formation. Peroxisome proliferator-activated receptor-alpha (PPARalpha), a member of the nuclear receptor family, regulates gene expression in response to certain fatty acids and fibric acid derivatives. The present study investigated PPARalpha expression in human ECs and their regulation of vascular cell adhesion molecule-1 (VCAM-1) |
| BEL:20045632 | 2-720 | p(HGNC:TNF) increases p(HGNC:VCAM1) | denotes | ARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. BACKGROUND: Adhesion molecule expression on the endothelial cell (EC) surface is critical for leukocyte recruitment to atherosclerotic lesions. Better understanding of transcriptional regulation of adhesion molecules in ECs may provide important insight into plaque formation. Peroxisome proliferator-activated receptor-alpha (PPARalpha), a member of the nuclear receptor family, regulates gene expression in response to certain fatty acids and fibric acid derivatives. The present study investigated PPARalpha expression in human ECs and their regulation of vascular cell adhesion molecule-1 (VCAM-1) |
| BEL:20044882 | 0-721 | p(HGNC:SELP) increases bp(GOBP:"cell adhesion") | denotes | PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. BACKGROUND: Adhesion molecule expression on the endothelial cell (EC) surface is critical for leukocyte recruitment to atherosclerotic lesions. Better understanding of transcriptional regulation of adhesion molecules in ECs may provide important insight into plaque formation. Peroxisome proliferator-activated receptor-alpha (PPARalpha), a member of the nuclear receptor family, regulates gene expression in response to certain fatty acids and fibric acid derivatives. The present study investigated PPARalpha expression in human ECs and their regulation of vascular cell adhesion molecule-1 (VCAM-1). |
| BEL:20044874 | 0-721 | p(HGNC:SELE) increases bp(GOBP:"cell adhesion") | denotes | PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. BACKGROUND: Adhesion molecule expression on the endothelial cell (EC) surface is critical for leukocyte recruitment to atherosclerotic lesions. Better understanding of transcriptional regulation of adhesion molecules in ECs may provide important insight into plaque formation. Peroxisome proliferator-activated receptor-alpha (PPARalpha), a member of the nuclear receptor family, regulates gene expression in response to certain fatty acids and fibric acid derivatives. The present study investigated PPARalpha expression in human ECs and their regulation of vascular cell adhesion molecule-1 (VCAM-1). |
| BEL:20042314 | 0-721 | p(HGNC:ICAM1) increases bp(GOBP:"cell adhesion") | denotes | PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. BACKGROUND: Adhesion molecule expression on the endothelial cell (EC) surface is critical for leukocyte recruitment to atherosclerotic lesions. Better understanding of transcriptional regulation of adhesion molecules in ECs may provide important insight into plaque formation. Peroxisome proliferator-activated receptor-alpha (PPARalpha), a member of the nuclear receptor family, regulates gene expression in response to certain fatty acids and fibric acid derivatives. The present study investigated PPARalpha expression in human ECs and their regulation of vascular cell adhesion molecule-1 (VCAM-1). |